Ayush Ministry Releases Treatment Guidelines for Skin Disorders Across Four Traditional Systems

1. At a Glance

• The Ministry of Ayush has issued Standard Treatment Guidelines (STGs) on the "Management of Dermatological Disorders". There is a separate document for each of Ayurveda, Siddha, Unani and Homoeopathy, and Yoga is included [1].
• The Ayush Vertical of the DGHS under the Ministry of Health & Family Welfare prepared them. This is an example of the Ayush and modern-medicine administrations working together [1].
• The aim is uniformity, quality assurance and evidence-informed practice in Ayush clinical care [1].
• Why it matters for UPSC: it links to integrative medicine, the WHO Traditional Medicine Strategy 2025–34, Ayush insurance coverage and AB-PMJAY, and the debate on evidence-based traditional medicine (GS-II health, GS-III S&T) [1][6][8].

2. Why in the News

• STGs on dermatological disorders were released for four Ayush systems plus Yoga. The press release came out on 13 Oct 2026 [1].
• They were released on the occasion of the 11th Ayurveda Day [1].
• They cover psoriasis, dermatitis, vitiligo, urticaria and dermatophytosis [1].

3. Background & Evolution

• Rationale: Clinical practice varies a lot across Ayush systems. The STGs try to standardise prevention, diagnosis, treatment, follow-up and rehabilitation while keeping each system's own principles [1].
• Milestones (chronological):
• 2023: Ayurveda Day theme was "Ayurveda for One Health" [10].
• 2024: The DGHS and Ayush jointly published STGs, which PIB called a "first-of-its-kind" integration in India. At a sensitisation event for insurers, Ayush hospitals were asked to adopt Ministry-approved STGs and ICD-TM2 codes to get insurance empanelment [6].
• 2024: 9th Ayurveda Day theme was "Ayurveda Innovation for Global Health" [11].
• STGs were discussed as one of the building blocks for adding Ayush packages to PM-JAY [7].
• The Ayush Vertical of DGHS had earlier issued STGs on common musculoskeletal disorders, covering Unani among other systems [5].
• May 2025: The 78th World Health Assembly adopted the WHO Traditional Medicine Strategy 2025–2034 [8].
• 2025: Ayurveda Day was fixed on 23 September every year, starting 2025 [3]. The 10th Ayurveda Day was held at AIIA Goa with the theme "Ayurveda for People & Planet" [4].
• Dec 2025: The 2nd WHO Global Summit on Traditional Medicine was held in New Delhi, co-organised with the Government of India [9].
• 2026: 11th Ayurveda Day had the theme "Ayurveda for a Healthier Tomorrow", and the national event was in Nagpur [2]. The dermatology STGs were released on this occasion [1].

4. Core Static Facts

Item	Fact
Document	STGs on "Management of Dermatological Disorders" [1]
Systems covered	Ayurveda, Siddha, Unani, Homoeopathy, plus Yoga [1]
Issued by	Ministry of Ayush [1]
Prepared by	Ayush Vertical, DGHS, MoHFW [1]
Conditions	Psoriasis, dermatitis, vitiligo, urticaria, dermatophytosis [1]
Scope per system	Prevention, diagnosis, treatment, follow-up, rehabilitation [1]
Contributors	Ayush Research Councils, academic experts in the four systems, Yoga experts, modern-medicine specialists [1]
Method	Expert consultations, classical-text review, evidence assessment, consensus deliberations [1]
Field validation	With the Directorate of Ayush, Govt of NCT of Delhi, through Medical Officers in primary and secondary care [1]
Union MoS (IC) Ayush	Shri Prataprao Jadhav (also MoS Health & FW) [1]
Secretary, Ayush	Vaidya Rajesh Kotecha [1]
DGHS	Dr. Loveneesh G. Krishna [1]
Ayurveda Day date	23 September every year, from 2025 [3]

5. Multi-Dimensional Analysis

Administrative / Governance

• An Ayush Vertical sitting inside the DGHS (MoHFW) produced the guidelines, so the Ayush ministry and the health ministry are working together rather than separately [1].
• Testing the guidelines with Delhi Medical Officers before release brought in feedback from actual users, which improves their practical usefulness [1].
• Health is a State subject, so uptake depends on State Ayush directorates adopting the STGs. The Delhi pilot is a model for this.

Scientific / Technological

• The guidelines combine classical texts with current evidence through consensus. They are "evidence-informed", which is weaker than "evidence-based" in the RCT sense [1].
• They give a standard reference that future research and outcome studies can be measured against [1].
• They fit WHO TM Strategy 2025–34 priorities: building the evidence base, ensuring safety and quality, and integrating with health services [8].

Economic

• Ayush hospitals are asked to adopt STGs and ICD-TM2 codes to get insurance empanelment [6]. STGs are also needed to design and cost Ayush packages under PM-JAY [7].
• Standard protocols make claims easier to verify and cost, which supports the market for Ayush services.

Social / Public health

• The covered conditions are common, chronic and often stigmatising, for example vitiligo and psoriasis. Ayush can offer a low-cost option at primary-care level [1].
• Risk: if practitioners don't follow referral rules, patients with serious skin disease may reach modern care late.

Geopolitical / Soft power

• India co-hosted the 2nd WHO Global TM Summit in New Delhi (Dec 2025) [9]. Standardised protocols strengthen India's case for global acceptance of Ayush.

Ethical

• Patient safety and informed consent matter here: steroid adulteration and heavy metals are known concerns with some products. Standard protocols help accountability, but they don't replace pharmacovigilance.

6. Recent Developments (last 12–18 months)

• May 2025: WHA78 adopted the WHO TM Strategy 2025–2034. The Director-General must report progress in 2030 and 2034 [8].
• 2025: Ayurveda Day fixed on 23 September [3]. The 10th edition was at AIIA Goa, theme "Ayurveda for People & Planet" [4].
• Dec 2025: 2nd WHO Global Summit on Traditional Medicine in New Delhi [9].
• Sept 2026: 11th Ayurveda Day, theme "Ayurveda for a Healthier Tomorrow", held in Nagpur [2].
• Oct 2026 (PIB date 13 Oct): Dermatology STGs released for four systems plus Yoga [1].

7. Prelims Hooks

• The dermatology STGs cover 4 systems (Ayurveda, Siddha, Unani, Homoeopathy) and include Yoga [1].
• Sowa-Rigpa is not one of the systems covered [1].
• Prepared by the Ayush Vertical of the DGHS, MoHFW. They were not drafted by an Ayush Research Council alone [1].
• Issued by the Ministry of Ayush [1].
• Conditions covered: psoriasis, dermatitis, vitiligo, urticaria, dermatophytosis [1].
• Dermatophytosis is a fungal (ringworm/tinea) infection. Urticaria is hives [1].
• Field validation was done with the Directorate of Ayush, Govt of NCT of Delhi [1].
• Released on the occasion of the 11th Ayurveda Day [1].
• Ayurveda Day is observed on 23 September every year from 2025. Before that it fell on Dhanteras, for example 29 Oct in 2024 [3][11].
• 2025 theme: "Ayurveda for People & Planet" (AIIA Goa) [4]. 2026 theme: "Ayurveda for a Healthier Tomorrow" (Nagpur) [2].
• The DGHS and Ayush joint STGs were called a "first-of-its-kind" integration [6].
• ICD-TM2 coding together with STGs is promoted for Ayush insurance empanelment [6].
• The Ayush Vertical had earlier issued STGs on musculoskeletal disorders [5].
• WHO TM Strategy 2025–2034 was adopted at WHA78 (May 2025) [8].
• The 2nd WHO Global Summit on Traditional Medicine was held in New Delhi, Dec 2025 [9].

8. The Strongest Objection: Is the Government Backing Unproven Cures?

• The objection, stated fairly
• The STGs are "evidence-informed". They are built from classical texts, expert opinion and consensus. They are not built only from randomised controlled trials (RCTs, studies that compare a treated group with an untreated group) [1].
• Critics say an official guideline makes a treatment look proven. A patient reads a government seal as proof that the treatment works.

• India's rules on testing were weak for a long time. The Drugs & Cosmetics Act, 1940 had no clear provisions for clinical trials of Ayurvedic medicines. The Ministry had to issue separate Good Clinical Practice guidelines to fill this gap [15].

• What the objection gets right

• Writing a treatment into a guideline does not prove that it works. The STGs do not claim RCT-level proof, and an answer should not claim it either [1].

• The Parliamentary Standing Committee found high metal content in Ayush drugs. So doubts about safety have official backing, not just efficacy doubts [12].

• Why the STGs are still a step forward

• Before the STGs, each practitioner treated in their own way. A single written protocol is easier to check, audit and test than hundreds of private styles [1].
• A fixed protocol can be tested. Researchers cannot run an outcome study on "whatever each doctor does". They can run one on a named treatment for psoriasis [1].

• The Standing Committee itself wants patient data on diagnosis, treatment and outcomes from local centres, to support large studies [12]. STGs give that data a common format.

• Balanced line for Mains: STGs are the starting point for building evidence. They are not the end of that process. Their value depends on whether outcome studies follow.

9. A Guideline Cannot Check What Is Inside the Medicine Bottle

• The STG controls the prescription, not the product
• An STG tells the doctor which medicine to give. It cannot make sure the medicine bought from the market is pure.

• The Standing Committee flagged high metal content in Ayush drugs. It asked for post-marketing surveillance (checking a medicine's safety after it is on sale) and a system to report adverse events [12].

• Very few safety problems get reported

• Pharmacovigilance means tracking harmful effects of medicines after people use them. An ADR (adverse drug reaction) is one such harmful effect.
• Since 2018, the Ayush pharmacovigilance network has recorded only 1,637 ADR reports, but 32,527 misleading advertisements [16].

• So the system catches false claims much more often than it catches actual harm to patients. A problem that is never reported stays invisible.

• False advertising is growing faster than enforcement

• Complaints about misleading Ayush ads rose from 7,771 (2023) to 10,161 (2024) to 16,129 (2025) [14].
• These complaints are passed on to State Licensing Authorities. They act under the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954 [14].

• Skin diseases matter here. Psoriasis and vitiligo are long-lasting and visible, so patients are easily drawn to ads that promise a "permanent cure". A careful STG at the clinic is weakened if TV ads promise more than it does.

• The Supreme Court had to push for monitoring

• The Ayush Suraksha portal (May 2025) collects reports on misleading ads and ADRs. It was built after a Supreme Court order of 30 July 2024 (WP (C) 645/2022). The order asked for a central dashboard [13].
• So safety monitoring started because a court ordered it, not as part of normal planning. STGs and safety monitoring are still two separate systems.

10. Why the Delhi Pilot Will Not Spread to the States on Its Own

• The STGs need working clinics and trained doctors

• The guidelines were tested with Medical Officers in Delhi's primary and secondary care [1]. Other States can use them only if they have similar facilities and staff.

• The National Ayush Mission shows how far behind the system is

• More than 69% of integrated Ayush hospitals approved under the Mission were still under construction [12].
• Only 65% of Ayush Health and Wellness Centres had been set up [12].

• Fund utilisation was low. In 2022-23, 85% of revised funds were used. The reasons were late release of funds, overlapping roles and delayed utilisation certificates [12].

• Why this matters for the STGs

• Health is a State subject. A central guideline becomes daily practice only when a State directorate trains its doctors and checks that they follow it.
• If a State cannot finish building its hospitals or spend its Mission funds, it is unlikely to run a training-and-audit programme for STGs.

11. Modern Medicine Is Being Asked for the Same Protocols

• This is not only an Ayush issue
• The Parliamentary Standing Committee on Health (175th–177th reports) asked MoHFW to prioritise disease-wise treatment protocols. It said standard treatment would reduce over-medicalisation (giving more tests and drugs than needed) [17].

• It asked the National Health Authority to recalibrate (reset) AB-PMJAY package costs using evidence-based clinical guidelines. It also wanted empanelled private hospitals to follow those protocols [17].

• What this means for the Ayush STGs

• Parliament wants the same rule for both systems: a protocol, linked to payment, and checked against evidence.
• Ayush STGs are already linked to insurance empanelment (official listing of a hospital as approved for insurance payments) [6][7]. The open question is whether they will be held to the same evidence standard that Parliament wants for allopathy.

12. What Should Happen Next, and Who Should Do It

• Ministry of Ayush and the Research Councils: test the STGs
• CCRAS, CCRS, CCRUM and CCRH helped write the STGs [1]. They should now run outcome studies on the five skin conditions using the same protocols.

• This follows the Standing Committee's advice to make research a part of the Mission and to standardise data collection [12].

• Ministry of Ayush: connect the STGs to safety reporting

• Every STG-based prescription is a chance to record side effects. Doctors following the STGs should report ADRs through the Ayush Suraksha portal [13].

• The data should be published on a dashboard, as the Supreme Court wanted [13].

• NHA and the Ministry of Ayush: pay only for treatment that follows the protocol

• Use the Standing Committee's model for allopathy here too: PM-JAY Ayush packages should be priced on the STGs, and hospitals should be required to follow them [17][7].

• State Ayush directorates: copy the Delhi field test

• Each State should test the STGs with its own Medical Officers, as Delhi did [1].

• The Standing Committee suggested financial incentives for States that implement the Mission well, and fewer budget line items. These tools can be used to support STG roll-out [12].

• Regulators: bring drug quality up to international standards

• The Standing Committee asked for Ayush medicine standards to be harmonised with international norms [12]. Without this, foreign countries will not accept Ayush treatment protocols, even if they are well written.

13. Anchors for Answers

• Data: Since 2018, 1,637 Ayush ADR reports against 32,527 misleading ads. Harm to patients is reported far less than false claims [16]
• Data: Misleading Ayush ad complaints: 7,771 (2023) → 10,161 (2024) → 16,129 (2025) [14]
• Data: More than 69% of approved integrated Ayush hospitals still under construction; only 65% of Ayush HWCs set up [12]
• Report/Committee: Parliamentary Standing Committee on Health & FW, Review of National Ayush Mission (Feb 2024). It flagged high metal content in Ayush drugs and recommended post-marketing surveillance and outcome data [12]
• Report/Committee: Standing Committee on Health, 175th–177th reports. Disease-wise protocols; PM-JAY costs to be based on evidence-based guidelines [17]
• Law/Case: Supreme Court order of 30 July 2024 in WP (C) 645/2022, which led to the Ayush Suraksha portal [13]. Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954 [14]. Drugs & Cosmetics Act, 1940 [15]
• Scheme: National Ayush Mission. STGs need its hospitals and HWCs to reach patients [12]. AB-PMJAY Ayush packages. STGs are the basis for pricing claims [7]

14. Mains Relevance

• GS-II: Issues relating to the development and management of the Social Sector/Services relating to Health. Government policies and interventions.
• GS-III: Science & Technology developments; Indigenous technology / traditional knowledge.
• GS-IV (marginal): Ethics in public health and patient safety.
• Question stems: 1. "Standard Treatment Guidelines are a necessary but insufficient condition for integrating Ayush into mainstream healthcare." Critically examine. (GS-II, 15 marks) 2. Discuss how evidence-informed standardisation of traditional medicine supports India's commitments under the WHO Traditional Medicine Strategy 2025–2034. (GS-II/III, 10 marks) 3. Integrative medicine can improve access but also raises concerns about safety and accountability. Analyse with reference to recent Ayush initiatives. (GS-II, 15 marks)

15. Related Topics to Study Next

• WHO TM Strategy 2025–2034 / WHO GCTM (Jamnagar): the global framework that India's standardisation work fits into [8][9].
• ICD-11 TM2 module: coding that makes Ayush diagnoses insurable and comparable [6].
• AB-PMJAY Ayush packages: STGs are needed to price and approve claims [7].
• Ayush Vertical in DGHS: the institutional bridge between MoHFW and Ayush [1][5].
• Musculoskeletal STGs: the earlier STG series from the same vertical [5].
• Ayurveda Day and its themes: fixed date from 2025, links to the release occasion [3].
• Ayush Research Councils (CCRAS, CCRS, CCRUM, CCRH): they contributed technical input [1][5].
• Drugs & Cosmetics Act and Ayush drug regulation: covers safety and quality of the medicines the STGs recommend.

16. NCERT Concepts to Revise

• Ayurveda (History): Ayurveda is the lead system covered by the guidelines and gives the Ayurveda Day occasion its meaning.
• Traditional knowledge (Economy): The guidelines are about standardising traditional healthcare knowledge, which is the core theme of the note.
• Standing committee (Polity): The note relies on Parliamentary Standing Committee findings on Ayush drug safety, hospitals and treatment protocols.
• Misleading advertising (Economy): Rising complaints about false Ayush cure claims show why guidelines alone cannot protect patients.
• Sowa Rigpa (History): A listed trap: this Ayush system is not covered by these skin guidelines.
• Yoga (History): Yoga is included alongside the four systems but has no separate guideline document.

17. Common Errors / Trap Areas

• Which body prepared them: the Ayush Vertical of the DGHS (MoHFW) prepared them, and the Ministry of Ayush issued them. Questions may swap these [1].
• Which systems are covered: Sowa-Rigpa and Naturopathy are not covered. Yoga is included, but there is no separate Yoga guideline document. The four PDFs are Ayurveda, Siddha, Unani and Homoeopathy [1].
• Ayurveda Day date: it is now 23 September [3]. Older material links it to Dhanteras or Dhanwantari Jayanti [11].
• Mixing up themes: 2023 "One Health" [10], 2024 "Innovation for Global Health" [11], 2025 "People & Planet" [4], 2026 "Healthier Tomorrow" [2].
• Evidence-informed vs evidence-based: the PIB text says "evidence-informed" (a consensus that includes classical texts). It does not claim RCT-validated efficacy [1].